Short Courses*

MONDAY, 19 MARCH 2018, 13:00 – 16:00

SC1: Optimizing Media for Culturing Cells - Detailed Agenda

To grow mammalian cells, researchers need to provide an optimal in vitro environment. The key feature of successful cell growth is the culture medium. “Achieving Super Soup” requires finesse and know-how in order to combine the right ingredients at the right times under the right conditions to achieve high titers. This workshop will provide a foundation for optimizing cell culture media presented by real-world experts who will also tailor a portion of the course to fit concerns and challenges faced by the workshop participants.

Tim Beckmann, PhD, Director, Strategic Development & USP, Xell AG 

Frederic Girard, PhD, Managing Director, Eurofins Spinnovation Analytical

Jochen B. Sieck, PhD, Head, Perfusion Systems and Cell Culture Media R&D, Merck Life Science

SC2: Continuous Processing Masterclass - Detailed Agenda

The manufacture of biopharmaceuticals using semi- or fully continuous processes has the potential to improve product quality and increase the productivity of biomanufacturing facilities. This Short Course details the principles and practical challenges of implementing a continuous process strategy. Using examples and shared experiences, the course covers continuous processing definitions and drivers, technologies and processes, process development and control, and quality considerations.

Instructor: Margit Holzer, PhD, Owner, Ulysse Consult

WEDNESDAY, 21 MARCH 2018, 18:30 – 21:00 | DINNER SHORT COURSES (Dinner Included)

SC3: At the Heart of PAT Lies the QbD Approach - Detailed Agenda

The QbD Roadmap provides a conceptual structure for the development activities of the drug manufacturing process. Coming from the Target Product Profile and subsequent determination of the Critical Quality Attributes (CQAs), the criticality of the process parameters that might have an impact on the CQAs are assessed using risk analysis. Subsequently, the impact of the critical process parameters (CPPs) on the CQAs is typically evaluated using a combined Design of Experiment and Data-driven process modeling strategy.


Gerald Striedner, PhD, Associate Professor, Biotechnology, University of Natural Resources and Life Sciences (BOKU)

Martin Mayer, MS, Head, Business Development, evon GmbH

Moritz von Stosch, PhD, Senior Manager, Fermentation, GlaxoSmithKline Pharma GmbH

*Separate Registration Required